187 related articles for article (PubMed ID: 30726142)
1. Proliferation of Cash-Only Buprenorphine Treatment Clinics: A Threat to the Nation's Response to the Opioid Crisis.
Van Zee A; Fiellin DA
Am J Public Health; 2019 Mar; 109(3):393-394. PubMed ID: 30726142
[No Abstract] [Full Text] [Related]
2. Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and payment characteristics, 2007-16.
Yang JC; Roman-Urrestarazu A; Brayne C
PLoS One; 2020; 15(3):e0229787. PubMed ID: 32126120
[TBL] [Abstract][Full Text] [Related]
3. Management of opioid-dependent patients: comparison of the cost associated with use of buprenorphine/naloxone or methadone, and their interactions with concomitant treatments for infectious or psychiatric comorbidities.
Roncero C; Domínguez-Hernández R; Díaz T; Fernández JM; Forcada R; Martínez JM; Seijo P; Terán A; Oyagüez I
Adicciones; 2015 Sep; 27(3):179-89. PubMed ID: 26437312
[TBL] [Abstract][Full Text] [Related]
4. Public policy statement on buprenorphine for opiate dependence and withdrawal.
J Addict Dis; 2004; 23(4):116-7. PubMed ID: 15534969
[No Abstract] [Full Text] [Related]
5. Opioid drug utilization and cost outcomes associated with the use of buprenorphine-naloxone in patients with a history of prescription opioid use.
Kaur AD; McQueen A; Jan S
J Manag Care Pharm; 2008 Mar; 14(2):186-94. PubMed ID: 18331120
[TBL] [Abstract][Full Text] [Related]
6. Changes in For-Profit Medication-Assisted Therapy Clinics in an Appalachian City.
Holt HD; Olsen M
South Med J; 2021 Feb; 114(2):70-72. PubMed ID: 33537785
[TBL] [Abstract][Full Text] [Related]
7. Buprenorphine Maintenance vs. Placebo for Opioid Dependence.
Raleigh MF
Am Fam Physician; 2017 Mar; 95(5):Online. PubMed ID: 28290640
[No Abstract] [Full Text] [Related]
8. New pharmacological tool approved for opioid addiction.
Sansovich D
HIV Clin; 2004; 16(3):9-11. PubMed ID: 15366107
[No Abstract] [Full Text] [Related]
9. Opioid Use Disorder and Pregnancy.
O'Donnell FT; Jackson DL
Mo Med; 2017; 114(3):181-186. PubMed ID: 30228577
[TBL] [Abstract][Full Text] [Related]
10. In brief: Buprenorphine/naloxone (Zubsolv) for opioid dependence.
Med Lett Drugs Ther; 2013 Oct; 55(1427):83. PubMed ID: 24129113
[No Abstract] [Full Text] [Related]
11. Clinical experience with fortnightly buprenorphine/naloxone versus buprenorphine in Italy: preliminary observational data in an office-based setting.
Amato P
Clin Drug Investig; 2010; 30 Suppl 1():33-9. PubMed ID: 20450244
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine charges to uninsured patients at top-ranked U.S. hospitals.
Niforatos JD; Dorner SC; Pescatore RM; Raja AS
Am J Emerg Med; 2019 Dec; 37(12):2253-2254. PubMed ID: 31047741
[No Abstract] [Full Text] [Related]
13. Availability of Extended-Release Buprenorphine to Treat Opioid Use Disorders Among Medicaid-Covered Patients.
Shover CL
Psychiatr Serv; 2021 Feb; 72(2):225-226. PubMed ID: 32907476
[No Abstract] [Full Text] [Related]
14. A Summary from the Institute for Clinical and Economic Review's New England Comparative Effectiveness Public Advisory Council.
Otuonye IS; Banken R; Kumar VM; Pearson SD
J Manag Care Spec Pharm; 2019 Jun; 25(6):630-634. PubMed ID: 31134864
[TBL] [Abstract][Full Text] [Related]
15. Physicians as Mediators of Health Policy: Acceptance of Medicaid in the Context of Buprenorphine Treatment.
Knudsen HK; Studts JL
J Behav Health Serv Res; 2019 Jan; 46(1):151-163. PubMed ID: 30069622
[TBL] [Abstract][Full Text] [Related]
16. Buprenorphine for opioid dependence.
Milne M; Crouch BI; Caravati EM
J Pain Palliat Care Pharmacother; 2009; 23(2):153-5. PubMed ID: 19492216
[TBL] [Abstract][Full Text] [Related]
17. Patients With Opioid Use Disorder Deserve Trained Providers.
Weimer MB; Tetrault JM; Fiellin DA
Ann Intern Med; 2019 Dec; 171(12):931-932. PubMed ID: 31766053
[No Abstract] [Full Text] [Related]
18. Tramadol dependence: treatment with buprenorphine/naloxone.
Ritvo JI; Koonce R; Thurstone CC; Causey HL
Am J Addict; 2007; 16(1):67-8. PubMed ID: 17364425
[No Abstract] [Full Text] [Related]
19. Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine.
Chou R; Ballantyne J; Lembke A
Ann Intern Med; 2019 Sep; 171(6):427-429. PubMed ID: 31450240
[No Abstract] [Full Text] [Related]
20. Making Amends for the Opioid Epidemic.
Sharfstein JM; Olsen Y
JAMA; 2019 Apr; 321(15):1446-1447. PubMed ID: 30990541
[No Abstract] [Full Text] [Related]
[Next] [New Search]
